Featured Story | By Nick Paul Taylor Arcutis Biotherapeutics has taken another step toward challenging Amgen for the plaque psoriasis market. With the FDA submission now in, Arcutis is nearing the approval of its topical spin on an oral AstraZeneca product. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Celltrion Healthcare is continuing to make the case for switching from intravenous to subcutaneous formulations of infliximab, with the latest data drop suggesting there may be benefits beyond convenience. read more By Nick Paul Taylor The Bill & Melinda Gates Foundation has committed cash to Nanoform. The funding, which comes weeks after Nanoform landed a partnership with Boehringer Ingelheim, will support work to use nanoparticle engineering technology to improve drug molecules. read more By Nick Paul Taylor Syros Pharmaceuticals is racing forward with its effort to develop an oral leukemia treatment, dosing the first patient in an early-phase study to lay the groundwork for a planned move into phase 3 next year. read more By Joseph Keenan Bayer started a voluntary recall of certain antifungal aerosol sprays after the drugmaker discovered the carcinogen benzene in samples of the products. read more Resources Sponsored By: Trial Interactive Check out the eTMF Implementation Quick Guide to see a checklist TMF experts developed to help you reduce risks, maintain compliance, and establish effective processes in your eTMF. This whitepaper addresses where AI can make the biggest impact in clinical trials. Sponsored by: Thermo Fisher Scientific Looking to accelerate your biotech company, but not sure where to start? Sponsored by: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: LabVantage Solutions Shift from data collection to data science. Add advanced analytics to your lab informatics platform to yield valuable, action-ready insights from LIMS and other data. Sponsored by: Thermo Fisher Scientific Integrate supply chain simulation into your early clinical trial planning to minimize risk in an uncertain supply chain environment, improve supply chain outcomes, and help streamline time-to-market for innovative therapies. Sponsored by: WCG Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. | 
.png){kind=logo}
